Suppr超能文献

治疗性抗凝治疗孤立性小腿肌静脉血栓形成的疗效和安全性——一项系统评价和荟萃分析。

Efficacy and safety of therapeutic anticoagulation for the treatment of isolated calf muscle vein thrombosis - a systematic review and meta-analysis.

作者信息

Huang Xu-Chen, Hu Xu-Hua, Wang Xiao-Ran, Zhou Chao-Xi, Wang Gui-Ying

机构信息

1 Fourth Hospital of Hebei Medical University, Shijiazhuang, China.

出版信息

Vasa. 2016 Nov;45(6):478-485. doi: 10.1024/0301-1526/a000569. Epub 2016 Sep 6.

Abstract

BACKGROUND

Diverse treatment suggestions range from monitoring with duplex examinations to therapeutic anticoagulation (TA) for managing isolated calf muscle vein thrombosis (ICMVT). However, the small sample sizes and low-level evidence provided by most studies in the literature mean that the benefits of promising new treatment protocols are unclear. Hence, this meta-analysis is intended to assess the efficacy and safety of TA for patients with ICMVT.

PATIENTS AND METHODS

Articles comparing TA with no anticoagulation (NA) or no therapeutic anticoagulation (NTA) in patients with ICMVT were collected from PubMed, the Cochrane Library, EMBASE, and Web of Science. The risk ratio (RR) and 95 % confidence interval (95 % CI) were generated for each outcome of interest. The data were pooled using a random-effects or fixed-effects model to evaluate differences in outcomes between the TA and control groups.

RESULTS

Five of 377 initially identified papers were included. One randomized controlled trial, one non-randomized controlled trial and three retrospective cohort studies (a total of 744 patients, 390 in the TA group and the remaining 354 in the NA or NTA group) were included in this meta-analysis. The occurrence of thrombosis progression was significantly less frequent in those who received TA compared with those receiving NTA (RR = 0.33, 95 % CI 0.20 to 0.54, p < 0.01). The rate of complete recanalization was higher, albeit not significantly, in the TA group than in the NTA group (RR = 1.96, 95 % CI 1.01 to 3.80, p = 0.05). None of the pooled outcomes were significantly different when comparing the TA and NA groups.

CONCLUSIONS

This study suggests that TA may result in a significant reduction in the rate of thrombosis progression and a marginally significant increase in the rate of complete recanalization for patients with ICMVT. Further studies are needed to confirm these findings and clarify whether the benefits of TA outweigh the potential harm.

摘要

背景

对于孤立性小腿肌肉静脉血栓形成(ICMVT)的治疗,有多种建议,从采用双功超声检查进行监测到进行治疗性抗凝(TA)。然而,文献中大多数研究的样本量小且证据水平低,这意味着有前景的新治疗方案的益处尚不清楚。因此,本荟萃分析旨在评估TA治疗ICMVT患者的疗效和安全性。

患者与方法

从PubMed、Cochrane图书馆、EMBASE和科学网收集比较TA与不抗凝(NA)或不进行治疗性抗凝(NTA)治疗ICMVT患者的文章。针对每个感兴趣的结局生成风险比(RR)和95%置信区间(95%CI)。使用随机效应或固定效应模型汇总数据,以评估TA组和对照组在结局方面的差异。

结果

在最初鉴定的377篇论文中,有5篇被纳入。本荟萃分析纳入了1项随机对照试验、1项非随机对照试验和3项回顾性队列研究(共744例患者,TA组390例,NA或NTA组其余354例)。与接受NTA的患者相比,接受TA的患者血栓进展的发生率显著更低(RR = 0.33,95%CI 0.20至0.54,p < 0.01)。TA组的完全再通率虽无显著差异,但高于NTA组(RR = 1.96,95%CI 1.01至3.80,p = 0.05)。比较TA组和NA组时,汇总的结局均无显著差异。

结论

本研究表明,TA可能会使ICMVT患者的血栓进展率显著降低,完全再通率略有显著提高。需要进一步研究来证实这些发现,并阐明TA的益处是否超过潜在危害。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验